Skip to main content

Clinical Trials Using Capecitabine

Review the clinical trials studying capecitabine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-87 of 87

Adaptive Radiation Therapy Boost for the Treatment of Rectal Cancer, The ARBOR Trial
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Neoadjuvant Chemotherapy Combined with Magnetic Resonance Image Guided Pelvic Adaptive Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, SMART TNT Study
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Toripalimab, Gemcitabine, and Docetaxel before Chemoradiation for the Treatment of Locoregionally Advanced EBV Positive Nasopharyngeal Cancer
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Adaptive Radiotherapy for the Treatment of Patients with Locally Advanced Anal Cancer
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Status: Active
Location: See ClinicalTrials.gov
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Status: Active
Location: See ClinicalTrials.gov
Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer
Status: Active
Location: See ClinicalTrials.gov
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
Status: Enrolling by Invitation
Location: See ClinicalTrials.gov
Dose Adjusted Fluoropyrimidine to Reduce Toxicity for Patients with Heterozygous DPYD Deficiency Receiving 5-Fluorouracil or Capecitabine for Cancer Treatment
Status: Active
Location: 10 locations
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Status: Active
Location: 3 locations